We are the Peptide Experts
JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the worldwide biomedical community with science and quality driven products and services.
Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the most recent ISO 9001:2015 regulations.
Our Quality Guarantee
Since 2004 JPT maintains an active quality management system that is annually reviewed, audited and certified by an independent certifcation body (TÜV Rheinland) to meet ISO 9001 standards. Therefore, we have installed complete process documentation and an early signaling procedure in case of problems.
NEW: PepMix Pools covering Conserved & Saisonal Influenza A & B Antigens
Based on recommendations, we added selected PepMix peptide pools covering antigens for hemagglutinin (HA) of the following Influenza A & B strains:
- PepMix Influenza A (HA/H3N2/Darwin/2021)
- PepMix Influenza A (HA/H1N1/Victoria/2019)
- PepMix Influenza A (HA/H1N1/Wisconsin/2019)
Meet JPT at these Fall 2022 Conferences!
We provide industry-leading peptide services and tools for various vaccine, cell and immune therapy approaches, clinical immune monitoring, and epitope & target discovery. SO come and find us at our booths and discuss your projects, and what our custom services, clinical services or catalog prodcuts can do for you.
Study Melanoma with Peptide Innovations & New Literature
Melanoma is associated with a high somatic mutation frequence and neo-antigen formation. The potential immunogenicity of such neo-antigens makes them strong candidates for personalized cancer therapy approaches. Therefore, we developed a large variety of readily available peptide-based tools and services...